You are here

Article Text

Article menu
Download PDFPDF
Editorial commentary
First approved treatment in children with multiple sclerosis slows brain atrophy

http://dx.doi.org/10.1136/jnnp-2019-322519

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Twitter @es_arman

    • Funding The authors have not declared a specific grant for this research from any funding agency in the public, commercial or not-for-profit sectors.

    • Competing interests I have received funding for travel from the US National Multiple Sclerosis Society, speaker’s honorarium (paid to my institution) from Biogen and At The Limits educational programme.

    • Patient consent for publication Not required.

    • Provenance and peer review Commissioned; internally peer reviewed.

    Linked Articles